Menu
Content/Inhalt
Home
|
Careers
|
Contact us
Search
Welcome
History
Social responsibility
Our companies
Debiopharm Group
Debiopharm S.A.
Debio R.P. S.A.
Debioclinic S.A.
Debiovision Inc.
Debioinnovation S.A.
Business Model
Strengths
Development capabilites
Preclinical
Clinical
Manufacturing
Regulatory
Innovative drug delivery and formulation
Partnering
Licensing-in
Licensing-out
Partners
Pipeline
Commercial Products
Eloxatin®
Decapeptyl®
News & Events
Press Releases
Awards
Publications
Conferences
News
19.06.2008
Le "Prix Debiopharm/Valais pour les Sciences de la Vie" honore un chimiste valaisan pour son procédé électrochimique novateur
15.05.2008
Debiopharm Signs License Agreement for Marketing of Salvacyl®/Moapar 3-month for Sexual Deviations
Home
News & Events
Publications
Debio 025
( 28 items )
Triptorelin / Decapeptyl / Trelstar
( 7 items )
Oxaliplatin – Eloxatin – Elplat
( 12 items )
Debio 9902 - ZT-1
( 8 items )
Debio 8609 Sanvar
( 1 items )
Archives
( 15 items )
